Nestmedic S.A. (WSE:NST)
0.6700
+0.0050 (0.75%)
At close: Aug 14, 2025
Nestmedic Revenue
Nestmedic had revenue of 420.44K PLN in the quarter ending June 30, 2025, with 262.07% growth. This brings the company's revenue in the last twelve months to 1.06M, down -5.59% year-over-year. In the year 2024, Nestmedic had annual revenue of 969.20K, down -37.39%.
Revenue (ttm)
1.06M
Revenue Growth
-5.59%
P/S Ratio
23.02
Revenue / Employee
354.96K
Employees
4
Market Cap
24.52M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 969.20K | -578.88K | -37.39% |
Dec 31, 2023 | 1.55M | -318.97K | -17.08% |
Dec 31, 2022 | 1.87M | 1.21M | 185.24% |
Dec 31, 2021 | 654.56K | 283.58K | 76.44% |
Dec 31, 2020 | 370.99K | -37.16K | -9.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.06B |
NEUCA | 12.82B |
Voxel | 556.98M |
Synektik Spólka Akcyjna | 623.20M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |